238 related articles for article (PubMed ID: 17397670)
1. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML;
J Am Coll Cardiol; 2007 Apr; 49(13):1427-33. PubMed ID: 17397670
[TBL] [Abstract][Full Text] [Related]
2. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
[TBL] [Abstract][Full Text] [Related]
3. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
[TBL] [Abstract][Full Text] [Related]
4. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
8. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
[TBL] [Abstract][Full Text] [Related]
9. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
11. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
Coats AJ
Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
[TBL] [Abstract][Full Text] [Related]
12. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
13. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
[TBL] [Abstract][Full Text] [Related]
15. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
Franqui-Rivera H; Sotomonte JC
P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.
Zareba W; Moss AJ; Jackson Hall W; Wilber DJ; Ruskin JN; McNitt S; Brown M; Wang H;
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1265-70. PubMed ID: 16403053
[TBL] [Abstract][Full Text] [Related]
20. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]